纳米材料介导的腺路径抑制用于加强癌症免疫治疗
Wenhu Zhu1, Fei Wu1, Zhanhong Qiao1
1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China.
Theranostics
|April 30, 2025
概括
纳米材料提供了一个有希望的解决方案,通过克服腺胺 (ADO) 抑制剂的局限性来增强癌症免疫疗法. 这种方法针对免疫抑制瘤微环境,提高治疗效率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 免疫疗法是一种关键的癌症治疗方法,但其有效性受到免疫抑制瘤微环境 (ITME) 的限制.
- 在ITME中的腺素 (ADO) 信号通过抑制抗原呈现和免疫细胞激活来抑制抗瘤免疫反应.
- 目前的ADO途径抑制剂面临着短半衰期和生物可用性差等挑战.
研究的目的:
- 审查腺在免疫抑制瘤微环境中的作用.
- 探索纳米材料在提供ADO抑制剂以增强免疫治疗方面的潜力.
- 概括纳米材料介导ADO路径抑制当前的策略和未来的挑战.
主要方法:
- 关于ADO免疫抑制机制的文献综述.
- 讨论各种纳米材料平台用于ADO抑制剂的输送.
- 对ADO抑制剂临床试验数据的分析.
主要成果:
- 氨酸在瘤内的免疫抑制中起着至关重要的作用.
- 纳米材料可以改善ADO抑制剂的药理动力学和输送.
- 不同的纳米材料,包括基于脂质的,基于聚合物的,中孔的,仿生的和基于金属的,显示出潜在的.
结论:
- 基于纳米材料的输送系统是克服传统ADO抑制剂局限性的有希望的策略.
- 这种方法有可能显著提高癌症免疫治疗的疗效.
- 需要进一步的研究和开发来将这些纳米药物转化为临床实践.
更多相关视频
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
10.9K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
